MedCodeSearch
HCPCS Level II Current in October 2026

J3375

Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg

Release
October 2026
Effective
Official source (opens in a new tab)

Version History

How J3375 appears in each release imported from the official files, newest first.

  1. October 2026 Effective

    Current

    Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg

  2. July 2026 Effective

    Revised
    Previous description
    Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg
    Description in this release
    Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg

  3. April 2026 Effective

    Unchanged

    Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg

  4. January 2026 Effective

    Unchanged

    Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg

Data Source

Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.

Release
October 2026
Effective
Source file
october-2026-alpha-numeric-hcpcs-file.zip

Official HCPCS Level II source files (opens in a new tab)

MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.

Look up another code

Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.